Description

Dengvaxia Tetravalent Vaccine: Uses, Side Effects, and Precautions

Dengvaxia Tetravalent Vaccine helps prevent dengue fever caused by all four dengue virus serotypes (DENV-1, DENV-2, DENV-3, and DENV-4). It is recommended for individuals with a prior dengue infection to reduce the risk of severe complications.

Dosage and Administration

• Given as a series of three subcutaneous injections over 12 months.
• Recommended for individuals aged 9-45 years with confirmed past dengue infection.
• Not advised for those without prior dengue exposure due to the risk of severe illness.

Common Side Effects

• Fever
• Headache
• Muscle pain
• Fatigue
• Mild injection site reactions (redness, swelling, or pain)

Serious Side Effects

• Increased risk of severe dengue in individuals without prior infection
• Allergic reactions (swelling, rash, difficulty breathing)
• Severe flu-like symptoms

Seek immediate medical attention if severe side effects occur.

Precautions and Warnings

• Only for individuals with confirmed past dengue infection.
• Not suitable for immunocompromised individuals or those with severe allergies.
• Consult a doctor before use if pregnant or breastfeeding.
• Does not provide complete immunity; continue preventive measures against mosquito bites.

Disclaimer

Products information mentioned on this site is for informative purposes only. The product image belongs to the respective company. Genetec Lifesciences is a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or authorized vendors of the company.